Latest News

Filters

Filter by tags: Canada South Africa Clear all tag filters

24 news articles found


South Africa’s Koya Capital has signed a partnership agreement with Stratek Global to assist in securing finance for construction of a high temperature modular reactor. The ZAR9bn ($480m) HTMR-100 is based on South Africa’s Pebble Bed Modular Reactor (PBMR).

Date: Friday, 12 April 2024
Original article: neimagazine.com/news/newssupport-grows-for-south-africas-htmr-100-smr-11676146

X-Energy UK Holdings, a wholly-owned subsidiary of US-based X-energy Reactor Company and Cavendish Nuclear, a wholly-owned subsidiary of Babcock International have been awarded funding from the UK Government’s Future Nuclear Enabling Fund (FNEF) to further the development of their plans to deploy Xe-100 advanced modular reactors (AMRs) in the UK. The government’s £3.34m ($4.23m) will be matched by X-energy for a total programme of £6.68m. The funds will be used to develop UK-specific deployment plans including an assessment of domestic manufacturing and supply chain opportunities, constructability, modularisation studies, and fuel management.

Date: Thursday, 11 April 2024
Original article: neimagazine.com/news/newsfunding-secured-to-accelerate-xe-100-deployment-in-the-uk-11671126

US-based X-energy Reactor Company and Canadian power company TransAlta Corporation have announced a partnership to study deployment of X-energy’s Xe-100 small modular reactors (SMRs) in Alberta. The study will be supported through funding from Emissions Reduction Alberta (ERA) and will assess the feasibility of repurposing a fossil fuel electricity generation site for an Xe-100 plant.

Date: Friday, 05 April 2024
Original article: neimagazine.com/news/newsx-energy-and-transalta-to-assess-use-of-xe-100-smrs-in-alberta-11658926

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Bangladesh is committed to continuous improvement of nuclear and radiation safety, an International Atomic Energy Agency (IAEA) team of experts has concluded. The Integrated Regulatory Review Service (IRRS) mission team identified areas for possible improvements.

Date: Friday, 16 December 2022
Original article: world-nuclear-news.org/Articles/IAEA-says-Bangladesh-committed-to-nuclear-safety

An International Atomic Energy Agency (IAEA) Integrated Regulatory Review Service (IRRS) mission said Bangladesh is committed to continuous improvement of nuclear and radiation safety. The mission also noted areas where improvements could be made to enhance the national nuclear and radiation safety regulatory infrastructure, as the country constructs its first nuclear power plant (NPP).

Date: Wednesday, 14 December 2022
Original article: neimagazine.com/news/newsiaea-reviews-bangladeshs-regulatory-framework-10433302

Powerful explosions shook the area of Ukraine’s Zaporizhzhia Nuclear Power Plant (ZNPP) on the evening of 19 November and the following morning, abruptly ending a period of relative calm at the facility and further underlining the urgent need for measures to help prevent a nuclear accident there, International Atomic Energy Agency (IAEA) Director General Rafael Mariano Grossi said on 20 November.

Date: Wednesday, 23 November 2022
Original article: neimagazine.com/news/newsshelling-resumes-damaging-zaporizhzhia-npp-while-conflict-also-affects-other-ukrainian-npps-10376039

An International Atomic Energy Agency (IAEA) Integrated Regulatory Review Service (IRRS) mission said Singapore is committed to maintaining and strengthening its regulatory framework for radiation safety and noted areas which would benefit from further enhancements.

Date: Saturday, 22 October 2022
Original article: neimagazine.com/news/newsiaea-reviews-singapores-regulatory-framework-for-radiation-safety-10106669

The head of the (pro-Russian) military-civil Administration of the Zaporizhzhia region, Yevhen Balitsky, has said the authorities plan to launch one of the six power units of the Zaporizhzhia Nuclear Power Plant (ZNPP) located in Energodar by winter. "We are working to ensure that we can still launch one unit, especially in winter. It may very well be that this will take place soon,” he told Solovyov Live.

Date: Thursday, 22 September 2022
Original article: neimagazine.com/news/newsshelling-resumes-at-zaporizhzhia-after-brief-lull-10022516